PREMIER CONSULTING Trademark

Trademark Overview

On Friday, October 22, 2021, a trademark application was filed for PREMIER CONSULTING with the United States Patent and Trademark Office. The USPTO has given the PREMIER CONSULTING trademark a serial number of 97088470. The federal status of this trademark filing is REGISTERED as of Tuesday, January 2, 2024. This trademark is owned by Premier Research International LLC. The PREMIER CONSULTING trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Pharmaceutical products development; Pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development and medical device and diagnostic research and development
premier consulting

General Information

Serial Number97088470
Word MarkPREMIER CONSULTING
Filing DateFriday, October 22, 2021
Status700 - REGISTERED
Status DateTuesday, January 2, 2024
Registration Number7264370
Registration DateTuesday, January 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"CONSULTING"
Goods and ServicesPharmaceutical research and development; Pharmaceutical products development; Pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development and medical device and diagnostic research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 8, 2021
Primary Code042
First Use Anywhere DateTuesday, February 22, 2022
First Use In Commerce DateTuesday, February 22, 2022

Trademark Owner History

Party NamePremier Research International LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMorrisville, NC 27560
Party NamePremier Research International LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMorrisville, NC 27560

Trademark Events

Event DateEvent Description
Tuesday, January 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 2, 2024REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, May 9, 2023EXPARTE APPEAL TERMINATED
Tuesday, May 9, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, May 8, 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, May 8, 2023USE AMENDMENT ACCEPTED
Monday, May 8, 2023EX PARTE APPEAL-INSTITUTED
Monday, May 8, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, May 8, 2023EXPARTE APPEAL RECEIVED AT TTAB
Friday, May 5, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, May 6, 2023AMENDMENT TO USE PROCESSING COMPLETE
Saturday, May 6, 2023USE AMENDMENT FILED
Friday, May 5, 2023TEAS AMENDMENT OF USE RECEIVED
Tuesday, November 8, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, November 8, 2022FINAL REFUSAL E-MAILED
Tuesday, November 8, 2022FINAL REFUSAL WRITTEN
Thursday, October 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 26, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 8, 2022NON-FINAL ACTION E-MAILED
Wednesday, June 8, 2022NON-FINAL ACTION WRITTEN
Monday, May 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 18, 2022NON-FINAL ACTION E-MAILED
Friday, March 18, 2022NON-FINAL ACTION WRITTEN
Friday, March 18, 2022ASSIGNED TO EXAMINER
Monday, November 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 26, 2021NEW APPLICATION ENTERED

Related Keywords

consulting premier development pharmaceutical research services device diagnostic medical field products